Christopher M. Yea
2021
In 2021, Christopher M. Yea earned a total compensation of $1.4M as Chief Development Officer at Carbylan Therapeutics, a 52% increase compared to previous year.
Compensation breakdown
| Bonus | $252,000 |
|---|---|
| Option Awards | $712,060 |
| Salary | $420,000 |
| Other | $25,341 |
| Total | $1,409,401 |
Yea received $712.1K in option awards, accounting for 51% of the total pay in 2021.
Yea also received $252K in bonus, $420K in salary and $25.3K in other compensation.
Rankings
In 2021, Christopher M. Yea's compensation ranked 7,519th out of 12,405 executives tracked by ExecPay. In other words, Yea earned more than 39.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,519 out of 12,405 | 39th |
Division Manufacturing | 3,308 out of 5,494 | 40th |
Major group Chemicals And Allied Products | 1,464 out of 2,369 | 38th |
Industry group Drugs | 1,304 out of 2,090 | 38th |
Industry Pharmaceutical Preparations | 959 out of 1,537 | 38th |
Source: SEC filing on August 14, 2023.
Yea's colleagues
We found two more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2021.